Theravance Bio: 4Q Earnings Snapshot

February 24, 2020 GMT

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Monday reported a loss of $65.6 million in its fourth quarter.

On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.17.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.11 per share.

The biopharmaceutical company posted revenue of $29.5 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $18.3 million.

For the year, the company reported that its loss widened to $236.5 million, or $4.25 per share. Revenue was reported as $73.4 million.


Theravance Bio shares have decreased 9% since the beginning of the year. In the final minutes of trading on Monday, shares hit $23.51, a fall of 7% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH